Amajor row has erupted between the European Union and the pharmaceuticals giant AstraZeneca over delays to deliveries of its new coronavirus vaccine to the 27-member bloc.
The EU says AstraZeneca, which is headquartered in Cambridge, is failing to fulfil its agreement to supply a certain quantity of the vaccine in the coming weeks.
AstraZeneca says it has simply run into some temporary production problems.
